[The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents].Zh Nevrol Psikhiatr Im S S Korsakova. 2008; 108(3):43-8.ZN
Abstract
The efficacy of piracetam in the treatment of the consequences of moderate and severe closed traumatic brain injury was assessed in 42 patients, aged 12-18 years, who suffered traumatic disorders 1,5-5 years before this study. Adolescents from the main group (20 patients) received piracetam in dosage of 40-50 mg/kg (or 1600-2400 mg daily) during one month. 22 patients of the second group were examined as controls. The positive therapeutic effects of piracetam on cognitive (memory, attention, executive functions) and motor (coordination) functions as well as the speed of cognitive and motor performance were demonstrated in this study.
MeSH
Pub Type(s)
Comparative Study
Evaluation Study
Journal Article
Language
rus
PubMed ID
18427539
Citation
Zavadenko, N N., and L S. Guzilova. "[The Consequences of Closed Traumatic Brain Injury and Piracetam Efficacy in Their Treatment in Adolescents]." Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova, vol. 108, no. 3, 2008, pp. 43-8.
Zavadenko NN, Guzilova LS. [The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(3):43-8.
Zavadenko, N. N., & Guzilova, L. S. (2008). [The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents]. Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova, 108(3), 43-8.
Zavadenko NN, Guzilova LS. [The Consequences of Closed Traumatic Brain Injury and Piracetam Efficacy in Their Treatment in Adolescents]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(3):43-8. PubMed PMID: 18427539.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents].
AU - Zavadenko,N N,
AU - Guzilova,L S,
PY - 2008/4/23/pubmed
PY - 2008/10/24/medline
PY - 2008/4/23/entrez
SP - 43
EP - 8
JF - Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
JO - Zh Nevrol Psikhiatr Im S S Korsakova
VL - 108
IS - 3
N2 - The efficacy of piracetam in the treatment of the consequences of moderate and severe closed traumatic brain injury was assessed in 42 patients, aged 12-18 years, who suffered traumatic disorders 1,5-5 years before this study. Adolescents from the main group (20 patients) received piracetam in dosage of 40-50 mg/kg (or 1600-2400 mg daily) during one month. 22 patients of the second group were examined as controls. The positive therapeutic effects of piracetam on cognitive (memory, attention, executive functions) and motor (coordination) functions as well as the speed of cognitive and motor performance were demonstrated in this study.
SN - 1997-7298
UR - https://www.unboundmedicine.com/medline/citation/18427539
DB - PRIME
DP - Unbound Medicine
ER -
Try the Free App:
